Editorial: Biosafety and Biosecurity Approaches to Counter SARS-CoV-2: From Detection to Best Practices and Risk Assessments

Front Bioeng Biotechnol. 2021 Aug 24:9:752909. doi: 10.3389/fbioe.2021.752909. eCollection 2021.

Authors

Segaran P Pillai¹, Jianming Qiu², Stephen A Morse³

Affiliations

¹ Office of the Commissioner, United States Food and Drug Administration, Silver Spring, MD, United States.
² Department of Microbiology, University of Kansas Medical Center, Kansas City, KS, United States.
³ IHRC, Inc, Atlanta, GA, United States.

No abstract available

Keywords: PPE; SARS-CoV2; best practices; biosafety and biosecurity; detection; diagnostics; risk assessments.

Publication types

Editorial